scholarly journals High-throughput screening in colorectal cancer tissue-originated spheroids

2018 ◽  
Vol 110 (1) ◽  
pp. 345-355 ◽  
Author(s):  
Jumpei Kondo ◽  
Tomoya Ekawa ◽  
Hiroko Endo ◽  
Kanami Yamazaki ◽  
Norio Tanaka ◽  
...  
2021 ◽  
Vol 108 (Supplement_1) ◽  
Author(s):  
MI Khot ◽  
M Levenstein ◽  
R Coppo ◽  
J Kondo ◽  
M Inoue ◽  
...  

Abstract Introduction Three-dimensional (3D) cell models have gained reputation as better representations of in vivo cancers as compared to monolayered cultures. Recently, patient tumour tissue-derived organoids have advanced the scope of complex in vitro models, by allowing patient-specific tumour cultures to be generated for developing new medicines and patient-tailored treatments. Integrating 3D cell and organoid culturing into microfluidics, can streamline traditional protocols and allow complex and precise high-throughput experiments to be performed with ease. Method Patient-derived colorectal cancer tissue-originated organoidal spheroids (CTOS) cultures were acquired from Kyoto University, Japan. CTOS were cultured in Matrigel and stem-cell media. CTOS were treated with 5-fluorouracil and cytotoxicity evaluated via fluorescent imaging and ATP assay. CTOS were embedded, sectioned and subjected to H&E staining and immunofluorescence for ABCG2 and Ki67 proteins. HT29 colorectal cancer spheroids were produced on microfluidic devices using cell suspensions and subjected to 5-fluorouracil treatment via fluid flow. Cytotoxicity was evaluated through fluorescent imaging and LDH assay. Result 5-fluorouracil dose-dependent reduction in cell viability was observed in CTOS cultures (p<0.01). Colorectal CTOS cultures retained the histology, tissue architecture and protein expression of the colonic epithelial structure. Uniform 3D HT29 spheroids were generated in the microfluidic devices. 5-fluorouracil treatment of spheroids and cytotoxic analysis was achieved conveniently through fluid flow. Conclusion Patient-derived CTOS are better complex models of in vivo cancers than 3D cell models and can improve the clinical translation of novel treatments. Microfluidics can streamline high-throughput screening and reduce the practical difficulties of conventional organoid and 3D cell culturing. Take-home message Organoids are the most advanced in vitro models of clinical cancers. Microfluidics can streamline and improve traditional laboratory experiments.


2016 ◽  
Vol 88 (5) ◽  
pp. 2792-2798 ◽  
Author(s):  
Christopher B. Raub ◽  
Chen-Chung Lee ◽  
Darryl Shibata ◽  
Clive Taylor ◽  
Emil Kartalov

2018 ◽  
Vol 38 (12) ◽  
pp. 6721-6727 ◽  
Author(s):  
SHINJI MATSUTANI ◽  
MASATSUNE SHIBUTANI ◽  
KIYOSHI MAEDA ◽  
HISASHI NAGAHARA ◽  
TATSUNARI FUKUOKA ◽  
...  

2003 ◽  
Author(s):  
Sotaro Sadahiro ◽  
Toshiyuki Suzuki ◽  
Kenji Ishikawa ◽  
Tomoki Nakamura ◽  
Akemi Kamijo ◽  
...  

2011 ◽  
Vol 42 (8) ◽  
pp. 478-481 ◽  
Author(s):  
Yong-qi Shen ◽  
Xian-bin Feng ◽  
Yong-rong Lai ◽  
Xue-jian Ning ◽  
Xian-ji Fan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document